Deep Dive
1. Purpose & Value Proposition
Enzyme aims to democratize asset management by moving it on-chain. Instead of relying on centralized funds, users can create, manage, and invest in customizable vaults that execute strategies via smart contracts. This reduces intermediaries, increases transparency, and opens sophisticated portfolio management to a broader audience. The platform serves both individual investors and institutions, as evidenced by partnerships like the one with CV5 Capital for tokenized fund issuance.
2. Technology & Architecture
The protocol is built on Ethereum and operates through its Enzyme Onyx stack. This infrastructure allows developers and fund managers to deploy "vault-as-a-service" products that can hold and automate strategies across various asset classes—from cryptocurrencies to real-world assets like commodities and U.S. Treasury bonds. The system emphasizes security with audited smart contracts and offers modularity for cross-chain operations.
3. Tokenomics & Governance
MLN is the network's utility token. Access to the protocol requires paying fees in MLN, calculated as 0.25% of the assets under management (AUM) in a vault. These paid tokens are automatically burned, creating a deflationary pressure. However, the tokenomics note that annual minting of up to 300,600 new MLN for development may offset burns in the short term. Governance is conducted by the Enzyme Council DAO, where MLN holders can vote on proposals and protocol upgrades.
Conclusion
Enzyme is fundamentally a decentralized engine for tokenized finance, providing the tools to build, manage, and scale investment strategies on-chain. As the infrastructure for this niche matures, how will its utility-driven tokenomics evolve to balance growth with sustainable value capture?